Recombinant spider silk particles as drug delivery vehicles

Biomaterials

Volumn 32, Issue 8, 2011, Pages 2233-2240

  Lammel, Andreas ^a   Schwab, Martin ^b   Hofer, Markus ^b   Winter, Gerhard ^b   Scheibel, Thomas ^a  

^a UNIVERSITY OF BAYREUTH   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Biodegradation; Biomimetics; Controlled release; Drug loading; Protein

Indexed keywords

ACIDIC ENVIRONMENT; BIODEGRADABLE CARRIERS; CONSTANT RELEASE; CONTROLLED RELEASE; DISTRIBUTION COEFFICIENT; DIVERSE APPLICATIONS; DRUG CARRIER; DRUG DELIVERY VEHICLES; DRUG LOADING; ELECTROSTATIC INTERACTIONS; ENZYMATIC DEGRADATION; HIGH POTENTIAL; IN-VITRO; LOADING EFFICIENCY; MECHANICAL CHARACTERISTICS; PARTICLE CHARACTERIZATION; PHYSIOLOGICAL CONDITION; RELEASE RATE; SILK FIBER; SILK PROTEINS; SMALL MOLECULES; SPIDER SILK PROTEIN; SPIDER SILKS; SUBMICRO-PARTICLES;

BIODEGRADATION; BIOMIMETICS; DEGRADATION; DRUG DELIVERY; LOADING; MICROBIOLOGY; PROTEINS;

SILK;

AMPHOPHILE; BIOPOLYMER; BIPERIDEN; CHLORTALIDONE; CRYSTAL VIOLET; EPHEDRINE; ETHACRIDINE LACTATE; METHYL PARABEN; PAPAVERINE; PARACETAMOL; PHENOLSULFONPHTHALEIN; PROCAINE; PROPRANOLOL; RECOMBINANT SPIDER SILK PROTEIN; TETRACAINE; UNCLASSIFIED DRUG;

ACIDITY; ALKALINITY; AQUEOUS SOLUTION; ARTICLE; COLLOID; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENZYMATIC DEGRADATION; IN VITRO STUDY; NONHUMAN; PARTICLE SIZE; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN ENGINEERING; STATIC ELECTRICITY;

ANIMALS; BIOCOMPATIBLE MATERIALS; DIFFUSION; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; MATERIALS TESTING; MODELS, MOLECULAR; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS; RECOMBINANT PROTEINS; SILK; SPIDERS;

ARACHNIDS; DRUGS; ENZYMATIC ACTIVITY; LOADING; MICROBIOLOGY; PROTEIN FIBERS; SILK;

ARANEAE;

EID: 78651468091     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.11.060     Document Type: Article

References (46)

1. Yasutomo N., Yoshiharu N., Masahisa W., Shigenori K., Jun M. Mechanical properties of silk fibroin-microcrystalline cellulose composite films. J Appl Polym Sci 2002, 86:3425-3429.
2. Vasir J.K., Tambwekar K., Garg S. Bioadhesive microspheres as a controlled drug delivery system. Int J Pharm 2003, 255:13-32.
3. Roser M., Fischer D., Kissel T. Surface-modified biodegradable albumin nano- and microspheres II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. Europ J Pharm Biopharm 1998, 46:255-263.
4. Uhrich K.E., Cannizzaro S.M., Langer R.S., Shakesheff M. Polymeric systems for controlled drug release. Chem Rev 1999, 99:3181-3198.
5. Allen T.M., Cullis P.R. Drug delivery systems: entering the mainstream. Science 2004, 303:1818-1822.
6. Edlund U., Albertsson A.C. Degradable polymer microspheres for controlled drug delivery. Degradable aliphatic polyesters 2002, 67-112. Springer, Berlin. A.C. Albertsson (Ed.).
7. Arshady R. Biodegradable microcapsular drug delivery systems: manufacturing methodology, release control and targeting prospects. J Bioact Compat Pol 1990, 5:315-342.
8. Altman G.H., Diaz F., Jakuba C., Calabro T., Horan R.L., Chen J., et al. Silk-based biomaterials. Biomaterials 2003, 24:401-416.
9. Freiberg S., Zhu X.X. Polymer microspheres for controlled drug release. Int J Pharm 2004, 282:1-18.
10. Langer R., Peppas N.A. Advances in biomaterials, drug delivery, and bionanotechnology. AIChE J 2003, 49:2990-3006.
11. George M., Abraham T.E. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan - a review. J Control Release 2006, 114:1-14.
12. Liu X., Sun Q., Wang H., Zhang L., Wang J.Y. Microspheres of corn protein, zein, for an ivermectin drug delivery system. Biomaterials 2005, 26:109-115.
13. Won Y.W., Kim Y.H. Recombinant human gelatin nanoparticles as a protein drug carrier. J Control Release 2008, 127:154-161.
14. Morlock M., Koll H., Winter G., Kissel T. Microencapsulation of rh-erythropoietin, using biodegradable poly(,-lactide-co-glycolide): protein stability and the effects of stabilizing excipients. Europ J Pharm Biopharm 1997, 43:29-36.
15. Soppimath K.S., Aminabhavi T.M., Kulkarni A.R., Rudzinski W.E. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001, 70:1-20.
16. Vandelli M.A., Rivasi F., Guerra P., Forni F., Arletti R. Gelatin microspheres crosslinked with, -glyceraldehyde as a potential drug delivery system: preparation, characterisation, in vitro and in vivo studies. Int J Pharm 2001, 215:175-184.
17. Sahin S., Selek H., Ponchel G., Ercan M.T., Sargon M., Hincal A.A., et al. Preparation, characterization and in vivo distribution of terbutaline sulfate loaded albumin microspheres. J Control Release 2002, 82:345-358.
18. Latha M.S., Rathinam K., Mohanan P.V., Jayakrishnan A. Bioavailability of theophylline from glutaraldehyde cross-linked casein microspheres in rabbits following oral administration. J Control Release 1995, 34:1-7.
19. Speer D.P., Chvapil M., Eskelson C.D., Ulreich J. Biological effects of residual glutaraldehyde in glutaraldehyde-tanned collagen biomaterials. J Biomed Mate Res 1980, 14:753-764.
20. Digenis G.A., Gold T.B., Shah V.P. Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance. J Pharm Sci 1994, 83:915-921.
21. Vollrath F., Barth P., Basedow A., Engström W., List H. Local tolerance to spider silks and protein polymers in vivo. In Vivo 2002, 16:229-234.
22. Allmeling C., Jokuszies A., Reimers K., Kall S., Choi C.Y., Brandes G., et al. Spider silk fibres in artificial nerve constructs promote peripheral nerve regeneration. Cell Prolif 2008, 41:408-420.
23. Lammel A., Keerl D., Römer L., Scheibel T. Proteins: polymers of natural origin. Recent advances in biomaterials research 2008, 1-22. Transworld Research Network, Trivandrum. J. Hu (Ed.).
24. Hardy J.G., Römer L.M., Scheibel T.R. Polymeric materials based on silk proteins. Polymer 2008, 49:4309-4327.
25. Römer L., Scheibel T. The elaborate structure of spider silk: structure and function of a natural high performance fiber. Prion 2008, 2:1-8.
26. Heim M., Keerl D., Scheibel T. Spider silk: from soluble protein to extraordinary fiber. Angew Chem Int Ed Engl 2009, 48:3584-3596.
27. Spieß K., Lammel A., Scheibel T. Recombinant spider silk proteins for applications in biomaterials. Macromol Biosci 2010, 10:998-1007.
28. Wenk E., Wandrey A.J., Merkle H.P., Meinel L. Silk fibroin spheres as a platform for controlled drug delivery. J Control Release 2008, 132:26-34.
29. Liebmann B., Hümmerich D., Scheibel T., Fehr M. Formulation of poorly water-soluble substances using self-assembling spider silk protein. Colloid Surf A 2008, 331:126-132.
30. Lammel A., Hu X., Park S.-H., Kaplan D., Scheibel T. Controlling silk fibroin particle features for drug delivery. Biomaterials 2010, 31:4583-4591.
31. Wang X., Wenk E., Matsumoto A., Meinel L., Li C., Kaplan D.L. Silk microspheres for encapsulation and controlled release. J Control Release 2007, 117:360-370.
32. Scheibel T. Spider silks: recombinant synthesis, assembly, spinning, and engineering of synthetic proteins. Microb Cell Fact 2004, 3:14.
33. Huemmerich D., Helsen C.W., Quedzuweit S., Oschmann J., Rudolph R., Scheibel T. Primary structure elements of spider dragline silks and their contribution to protein solubility. Biochemistry 2004, 43:13604-13612.
34. Slotta U.K., Rammensee S., Gorb S., Scheibel T. An engineered spider silk protein forms microspheres. Angew Chem Int Ed Engl 2008, 47:4592-4594.
35. Rammensee S., Slotta U., Scheibel T., Bausch A.R. Assembly mechanism of recombinant spider silk proteins. P Natl Acad Sci USA 2008, 105:6590-6595.
36. Lammel A., Schwab M., Slotta U., Winter G., Scheibel T. Processing conditions for the formation of spider silk microspheres. Chem Sus Chem 2008, 1:413-416.
37. Morrison I.D., Ross S. Sizing by light scattering. Colloidal dispersions - suspensions, emulsions and foams 2002, 87-94. John Wiley & Sons, New York. I.D. Morrison, S. Ross (Eds.).
38. Riley T., Govender T., Stolnik S., Xiong C.D., Garnett M.C., Illum L., et al. Colloidal stability and drug incorporation aspects of micellar-like PLA-PEG nanoparticles. Colloid Surf B 1999, 16:147-159.
39. Boyer The enzymes - volume III 1971, Academic Press, New York, p. 323-373.
40. Tamm L.K., Tatulian S.A. Infrared spectroscopy of proteins and peptides in lipid bilayers. Q Rev Biophys 1997, 30:365-429.
41. Shard A.G., Tomlins P.E. Biocompatibility and the efficacy of medical implants. Regen Med 2006, 1:789-800.
42. Schlosser M., Wilhelm L., Urban G., Ziegler B., Ziegler M., Zippler R. Immunogenicity of polymeric implants: long-term antibody response against polyester (Dacron) following the implantation of vascular prostheses into LEW.1A rats. J Biomed Mater Res 2002, 61:450-457.
43. Nair L.S., Laurencin C.T. Biodegradable polymers as biomaterials. Prog Polym Sci 2007, 32:762-798.
44. Shimizu T., Yamashiro Y., Igarashi J., Fujita H., Ishimoto K. Increased serum trypsin and elastase-1 levels in patients undergoing l-asparaginase therapy. Europ J Pediatrics 1998, 157:561-563.
45. Del Favero G., Fabris C., Plebani M., Panucci A., Piccoli A., Perobelli L., et al. Serum elastase 1 in chronic pancreatic disease. J Mol Med 1985, 63:603-606.
46. Page M.J., DiCera E. Serine proteases and serine protease inhibitors. Encyclopedia of chemical biology 2008, John Wiley & Sons, New York. T.P. Begley (Ed.).